In vivo microdialysis evidence that midazolam facilitates propofol-induced reduction in rat accumbal dopamine release
✍ Scribed by Yukihiro Yoshida; Shigeyo Koide; Noriya Hirose; Koji Takada; Tadashi Saigusa; Noriaki Koshikawa
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 949 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0893-6609
No coin nor oath required. For personal study only.
✦ Synopsis
The aim of this study was to determine whether propofol reduces extracellular concentrations of do amine in the rat nucleus accumbens and, if so, whether this effect is potentiated by mi B azolam. Propofol and midazolam were administered intravenously, via the external jugular vein, to freely-moving rats. The extracellular concentrations of dopamine in the nucleus accumbens were measured consecutively every 25 min by using in vivo brain microdialysis with electrochemical detection. Propofol(2.5,5.0 and 10.0 mg/kg) decreased the accumbal do amine concentrations in a dose-dependent manner. The largest dose (10.0 mg/kg P decreased dopamine concentration by a maximum of 34% (P c 0.01) at its peak effect. The smallest dose of propofol (2.5 mg/kg) did not affect dopamine concentrations when given alone, but decreased concentrations by 23% (P < 0.05) when combined with a dose of midazolam (0.075 mg/kg) having only a minimal effect on dopamine concentrations. The present study demonstrates that propofol dose-dependently reduces dopamine release m rat nucleus accumbens, and that the effect is facilitated by midazolam; a similar interaction is also seen clinically, on preoperative anxiety and on anaesthesia.